Akèy › Kansè nan tete › Florid › Cape Coral
Etid klinik pou Kansè nan tete nan Cape Coral, FL
10 etid pou Kansè nan tete ap chèche patisipan nan sit nan ak bò kote Cape Coral (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Ap rekriteFaz 3
- Florida Cancer Specialists-South, Fort Myers · 8 mi lwen
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Ap rekriteFaz 2
- Florida Cancer Specialists & Research Institute - Fort Myers Cancer Center - Gladiolus, Fort Myers · 8 mi lwen
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Regional Cancer Center-Lee Memorial Health System, Fort Myers · 8 mi lwen
- Schulze Family Foundation Cancer Clinic - Bonita Health Center, Bonita Springs · 19 mi lwen
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Ap rekriteFaz 3
- Florida Cancer Specialists - South ( Site 7004), Fort Myers · 8 mi lwen
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Ap rekriteFaz 3
- Florida Oncology & Hematology, Fort Myers · 8 mi lwen
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Ap rekriteFaz 3
- Florida Cancer Specialists, Fort Myers · 8 mi lwen
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Ap rekriteFaz 3
- Florida Cancer Specialists, Fort Myers · 8 mi lwen
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
Ap rekriteFaz 1/2
- Florida Cancer Specialists, Fort Myers · 8 mi lwen
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Ap rekriteFaz 1/2
- USOR Florida Cancer Specialists South, Fort Myers · 8 mi lwen
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Ap rekriteFaz 3
- Regional Cancer Center-Lee Memorial Health System, Fort Myers · 8 mi lwen
Etid Kansè nan tete nan lòt vil
- New York City, NY136 etid
- Houston, TX126 etid
- Boston, MA112 etid
- Nashville, TN81 etid
- Los Angeles, CA73 etid
- Edison, NJ68 etid
- St. Louis, MO64 etid
- Queens, NY64 etid
- Durham, NC64 etid
- Chicago, IL59 etid
- Philadelphia, PA56 etid
- Dallas, TX55 etid
Lòt etid nan Cape Coral
- Kansè Poumon ki pa ti selil12 etid
- Kansè kolorektal10 etid
- Maladi Alzheimer9 etid
- Kansè (tout kalite)7 etid
- Kansè Endomèt7 etid
- Kansè ovè7 etid
- Maladi fwa steatotik6 etid
- Leksemi mieloïd egi6 etid
- Kansè lestomak5 etid
- Obèsite5 etid
- Kansè Metastatik5 etid
- Kansè poumon5 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.